Frontlight ResearchEarly access
Haemophilia trials in Japan
4 of 13 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in JapanAn Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Children With Hemophilia A
- Where
- Many Locations
- Age
- 7 years to 12 years
- People
- 40 worldwide
- Run by
- Bayer
See details and how to joinNCT07088458 - No phaseTaking peopleA Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A
- Where
- Tokyo
- People
- 25
- Run by
- Takeda
See details and how to joinNCT06461533 - No phaseEnrolling by invitationPost-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors
- Where
- Aomori, Fukuoka, Hokkaido, Kagoshima, Kanagawa, Kitakyusyu-shi, Fukuoka, Okinawa, Tokyo, Toshima City
- People
- 23
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06285071 - No phaseEnrolling by invitationPost-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo
- Where
- Chiba, Fukui, Fukushima, Hyōgo, Kanagawa, Kawagoe, Miyagi, Nagano, Nahano, Okinawa, Osaka, Saitama, Shimane, Shizuoka, Tokyo, Yamagata, Yokohama-shi, Kanagawa
- Age
- 12 years and over
- People
- 30
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06831734